Transdermal delivery system is possible to transport PGV-0. This study was aimed 1) to formulate PGV-0 transdermal matrix with optimal physicochemical characteristics and release rate, 2) to establish the in vitro transport profile of transdermal PGV-0 across the skin. The combination of PVP and methylcellulose in transdermal matrix of PGV-0 was determined by Design Expert 7.1.5. The physicocemical characteristics consist of weight, thickness, % moisture content, % moisture uptake, folding endurance, and drug content were evaluated. PGV-0 release rate was tested using Millipore membrane in a vertical diffusion cells for 6 hours. Optimization of the matrix formula was performed based on the significant responses. Transdermal transport study ...
The purpose of this research was to develop a matrix-type transdermal therapeutic system containing ...
Ketoprofen is a propionic acid derivative that has anti-inflammatory, analgesic, and antipyreticacti...
A major concern for transdermal drug delivery systems is the low bioavailability of targeted drugs p...
PGV-0 delivery in oral route is difficult due to the high intensity of first-pass metabolism. Delive...
Transdermal delivery is one of the alternative delivery system to avoid the high intensity of first ...
Abstract: Transdermal delivery system is one of the delivery system for Pentagamavunon-0 (PGV-0) toa...
Objective: The objective of research work was to improve the permeability of Ketoprofen and to provi...
The present study was aims to formulate and evaluate transdermal drug delivery for sustained release...
The present study was aims to formulate and evaluate transdermal drug delivery for sustained release...
Transdermal patches of telmisartan with matrix type were prepared by solvent evaporation technique. ...
Delivery of losartan in a transdermal patch dosage form is challengging in terms of formulation due ...
Muhammad Rouf Akram,1 Mahmood Ahmad,1 Asad Abrar,1 Rai Muhammad Sarfraz,2 Asif Mahmood3 1Faculty of...
The nanoparticle in transdermal drug delivery system has been widely developed rapidly to increase s...
Transdermal therapeutic systems (TTS) containing captopril were developed by using synthetic and pH ...
© 2016, Controlled Release Society. The present study aimed to develop matrix-type transdermal drug ...
The purpose of this research was to develop a matrix-type transdermal therapeutic system containing ...
Ketoprofen is a propionic acid derivative that has anti-inflammatory, analgesic, and antipyreticacti...
A major concern for transdermal drug delivery systems is the low bioavailability of targeted drugs p...
PGV-0 delivery in oral route is difficult due to the high intensity of first-pass metabolism. Delive...
Transdermal delivery is one of the alternative delivery system to avoid the high intensity of first ...
Abstract: Transdermal delivery system is one of the delivery system for Pentagamavunon-0 (PGV-0) toa...
Objective: The objective of research work was to improve the permeability of Ketoprofen and to provi...
The present study was aims to formulate and evaluate transdermal drug delivery for sustained release...
The present study was aims to formulate and evaluate transdermal drug delivery for sustained release...
Transdermal patches of telmisartan with matrix type were prepared by solvent evaporation technique. ...
Delivery of losartan in a transdermal patch dosage form is challengging in terms of formulation due ...
Muhammad Rouf Akram,1 Mahmood Ahmad,1 Asad Abrar,1 Rai Muhammad Sarfraz,2 Asif Mahmood3 1Faculty of...
The nanoparticle in transdermal drug delivery system has been widely developed rapidly to increase s...
Transdermal therapeutic systems (TTS) containing captopril were developed by using synthetic and pH ...
© 2016, Controlled Release Society. The present study aimed to develop matrix-type transdermal drug ...
The purpose of this research was to develop a matrix-type transdermal therapeutic system containing ...
Ketoprofen is a propionic acid derivative that has anti-inflammatory, analgesic, and antipyreticacti...
A major concern for transdermal drug delivery systems is the low bioavailability of targeted drugs p...